BackHeat Biologics Overview

Heat Biologics Cost of Revenue

Cost of Revenue analysis for HTBX.

Quarterly Cost of Revenue

$145.37B

As of Sep 30, 2025

Annual Cost of Revenue (TTM)

$3931.43B

Trailing 12 months ending Sep 30, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)